HES1 and metabolic dysfunction-associated steatohepatitis: In the realm of NAFLD, the number of hepatocytes expressing a major Notch outcome product – Hes Family BHLH Transcription Factor 1 (Hes1) – is significantly elevated in patients with severe NASH (67), suggesting overt activation of this pathway.